abstract |
The present invention discloses esters of 4,9-dihydroxy-naphtho [2,3-b] furan and methods for making and using the same. The present invention also discloses the conversion of an ester in vivo to a therapeutically active 4,9-dihydroxy-naphtho [2,3-b] furan. The present invention further discloses pharmaceutical compositions comprising esters of 4,9-dihydroxy-naphtho [2,3-b] furan for the treatment of various indications including proliferative diseases. [Selection] Figure 1 |